Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Fipronil + (S)-methoprene** is a topical spot-on combination ectoparasiticide primarily used for dogs and cats to control flea and tick infestations. **Fipronil**, a phenylpyrazole insecticide, disrupts the parasites' nervous system by blocking GABA-gated chloride channels and glutamate-gated chloride channels, leading to hyperexcitation, paralysis, and death of adult fleas, ticks, and lice upon contact. **(S)-methoprene**, a juvenile hormone analog and insect growth regulator, mimics insect hormones to inhibit the maturation of flea eggs and larvae into adults, effectively breaking the flea life cycle and preventing environmental reinfestation. Applied monthly between the shoulder blades, it provides rapid kill of existing parasites within 24-48 hours and residual protection for up to 4-5 weeks, aiding in flea allergy dermatitis management and reducing transmission of tick-borne diseases like babesiosis and ehrlichiosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fipronil + (S)-methoprene.